48 results
S-3
EX-1.2
MREO
Mereo Biopharma Group Plc
15 May 24
Shelf registration
4:49pm
2000 (the “FSMA”).
(oo) Anti-Corruption Laws. None of the Company, its Subsidiaries or to the knowledge of the Company, any director, officer, agent … 2010, or any other applicable anti-bribery or anti-corruption law; and (iv) made, offered, authorized, requested, or taken an act in furtherance of any
10-K
2023 FY
EX-10.30
MREO
Mereo Biopharma Group Plc
27 Mar 24
Annual report
5:20pm
the FD&C Act or becoming an article that may not, under the FD&C Act, be introduced into interstate commerce); and
(f)Anti-Bribery and Anti-Corruption … are required to comply with all Applicable Law, including applicable local and international anti-bribery and anti-corruption laws and regulations
10-K
2023 FY
MREO
Mereo Biopharma Group Plc
27 Mar 24
Annual report
5:20pm
before and after grant of the MA, manufacturing of pharmaceutical products, statutory health insurance, bribery and anti-corruption or with other … with the requirements of these laws could adversely affect our financial condition.
Due to our international operations, we are subject to anti-corruption laws
S-8
EX-5.1
5fc6nnn
13 Jan 22
Registration of securities for employees
4:31pm
F-3/A
EX-5.1
rpk0h64xlpj2goj 27im
7 Sep 21
Shelf registration (foreign) (amended)
4:06pm
F-3
EX-1.2
f95q8ovynbj37kacx
5 Aug 21
Shelf registration (foreign)
4:33pm
F-3
EX-5.1
519jl 6358
5 Aug 21
Shelf registration (foreign)
4:33pm
6-K
EX-5.1
lvq3uzeea1mqyl1fi8c
10 Feb 21
Mereo BioPharma Group plc Announces Proposed Public Offering of American Depositary Shares
5:23pm
S-8
EX-5.1
ral17nac4bb9420kzj
15 Jan 21
Registration of securities for employees
4:21pm